Syncona Limited Director Information (0899D)
June 21 2019 - 11:18AM
UK Regulatory
TIDMSYNC
RNS Number : 0899D
Syncona Limited
21 June 2019
Syncona Limited
Director Information
21 June 2019
Syncona Limited announces that Nick Moss, a Non-Executive
Director, has informed the Company that he has retired from the
Board of BH Global Limited, a company listed on the London Stock
Exchange, with effect from 21 June 2019.
[ENDS]
Enquiries
Syncona Ltd
Annabel Clay / Siobhan Weaver
Tel: +44 (0) 20 3981 7940
Citco Fund Services (Guernsey) Limited
Company Secretary
Tel: +44 (0) 1481 758228
About Syncona:
Syncona is a leading FTSE250 healthcare company focused on
founding, building and funding global leaders in life science. Our
vision is to deliver transformational treatments to patients in
truly innovative areas of healthcare while generating superior
returns for shareholders.
We seek to partner with the best, brightest and most ambitious
minds in science to build globally competitive businesses. We take
a long-term view, underpinned by a deep pool of capital, and are
established leaders in gene and cell therapy. We focus on
delivering dramatic efficacy for patients in areas of high unmet
need.
Copies of this press release, a company results presentation,
and other corporate information can be found on the company website
at: www.synconaltd.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RDNEFLFLKQFFBBQ
(END) Dow Jones Newswires
June 21, 2019 11:18 ET (15:18 GMT)
Syncona (LSE:SYNC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Syncona (LSE:SYNC)
Historical Stock Chart
From Apr 2023 to Apr 2024